论文部分内容阅读
Liver transplantation (LT) is the only curative option for simultaneous hepatocellular carcinoma (HCC) and cirrhosis induced by hepatitis B virus (HBV) infection. However, the recurrence rate of HCC after LT is high, and intrahepatic recurrence of the primary tumor and de novo HCC occur frequently in the transplanted liver[1].